Central pontine myelinolysis

Jump to navigation Jump to search

For patient information, click here

Central pontine myelinolysis
Pons labeled at bottom left
ICD-10 G37.2
DiseasesDB 2198
MedlinePlus 000775
MeSH D017590

WikiDoc Resources for Central pontine myelinolysis

Articles

Most recent articles on Central pontine myelinolysis

Most cited articles on Central pontine myelinolysis

Review articles on Central pontine myelinolysis

Articles on Central pontine myelinolysis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Central pontine myelinolysis

Images of Central pontine myelinolysis

Photos of Central pontine myelinolysis

Podcasts & MP3s on Central pontine myelinolysis

Videos on Central pontine myelinolysis

Evidence Based Medicine

Cochrane Collaboration on Central pontine myelinolysis

Bandolier on Central pontine myelinolysis

TRIP on Central pontine myelinolysis

Clinical Trials

Ongoing Trials on Central pontine myelinolysis at Clinical Trials.gov

Trial results on Central pontine myelinolysis

Clinical Trials on Central pontine myelinolysis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Central pontine myelinolysis

NICE Guidance on Central pontine myelinolysis

NHS PRODIGY Guidance

FDA on Central pontine myelinolysis

CDC on Central pontine myelinolysis

Books

Books on Central pontine myelinolysis

News

Central pontine myelinolysis in the news

Be alerted to news on Central pontine myelinolysis

News trends on Central pontine myelinolysis

Commentary

Blogs on Central pontine myelinolysis

Definitions

Definitions of Central pontine myelinolysis

Patient Resources / Community

Patient resources on Central pontine myelinolysis

Discussion groups on Central pontine myelinolysis

Patient Handouts on Central pontine myelinolysis

Directions to Hospitals Treating Central pontine myelinolysis

Risk calculators and risk factors for Central pontine myelinolysis

Healthcare Provider Resources

Symptoms of Central pontine myelinolysis

Causes & Risk Factors for Central pontine myelinolysis

Diagnostic studies for Central pontine myelinolysis

Treatment of Central pontine myelinolysis

Continuing Medical Education (CME)

CME Programs on Central pontine myelinolysis

International

Central pontine myelinolysis en Espanol

Central pontine myelinolysis en Francais

Business

Central pontine myelinolysis in the Marketplace

Patents on Central pontine myelinolysis

Experimental / Informatics

List of terms related to Central pontine myelinolysis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: CPM; osmotic demyelination syndrome; osmotic myelinolysis; central pontine myelinosis

Overview

Central pontine myelinolysis is a neurologic disease caused by severe damage of the myelin sheath of nerve cells in the brainstem, more precisely in the area termed the pons. It is a complication of treatment of patients with profound, life threatening hyponatraemia. It occurs as a consequence of a rapid rise in serum tonicity following treatment in individuals with chronic severe hyponatraemia who have made intracellular adaptations to the prevailing hypotonicity. It can also occur as a complication of correcting hypernatremia too rapidly.

Pathophysiology

The currently accepted theory states that the brain cells adjust their osmolarities by changing levels of certain osmolytes like Inositol, Betaine, and Glutamine. In hyponatremia the levels of these osmolytes fall, preventing entry of free-water into cells. The reverse is true for hypernatremia. So rapid correction of sodium in hyponatremia would cause the extra cellular fluid to be relatively hypertonic. Free-water would then move out of the cells. This leads to central pontine myelinolysis. Rapid correction of hypernatremia causes water to move into cells, leading to multiple cerebral hemorrhages, equally catastrophic as osmotic demyelination.

Causes

The most common cause is the rapid correction of low blood sodium levels (hyponatremia). Over rapid correction of high levels of salt in the blood (hypernatremia) can also cause the condition.

Risk Factors

It has been postulated that one underlying cause may be the lack of a substance that is essential for brain activity and is lacking due to malnutrition. The fact that this condition is most frequently observed in patients with general ill health (alcoholism, cachexia etc.) is in accordance with this hypothesis. [1]

Diagnosis

Symptoms

MRI

Imaging by MRI demonstrates an area of high signal return on T2 weighted images.

Treatment

To avoid myelinolysis, the correction of hyponatremia should not exceed 1 mEq/L per hour. [2][3] There is no specific treatment and the syndrome is associated with high mortality and morbidity. This being a potentially avoidable disaster, following recommendations may be adhered to while maintaining sodium levels:

Hyponatremia

Correction rate=0.5-1.0meq/L/hr, with not more than 12meq/l correction in 24 hrs. If the patient has seizures (or [Na+]<115), correction can be attempted at up to 2meq/L/hr, but only till seizure activity lasts and [Na+] reaches above 125-130 meq/L.

Hypernatremia

Correct at 0.5meq/L/hr. Not more than 12 meq/L/24hrs.

References

  1. Adams RA, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholics and malnourished patients. Arch Neurol Psychiatry. 1959;81:154–72. PMID 13616772
  2. Kleinschmidt-DeMasters BK, Norenberg MD. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science. 1981;211(4486):1068-70. PMID 7466381
  3. Laureno R. Experimental pontine and extrapontine myelinolysis. Trans Am Neurol Assoc. 1980;105:354-8. PMID 7348981

Template:Diseases of the nervous system de:Zentrale pontine Myelinolyse

Template:WH Template:WS